Citi analyst Patrick Donnelly raised the firm’s price target on Quest Diagnostics (DGX) to $185 from $165 and keeps a Buy rating on the shares post the Q3 report. Integrating LifeLabs was the ...
This move would expand on existing rules that already limit the export of AI chips to more than 40 countries, including many in West Asia and Africa. The Biden administration plans to avoid AI chips ...